AB3A fundamentals
An in-depth look to SAREPTA THERA INC operating, investing, and financing activities
AB3A free cash flow for Q1 24 is -247.65 M CHF. For 2023, AB3A free cash flow was -485.88 M CHF and operating cash flow was -421.8 M CHF.
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: CHF
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
TTM